MedPath

Evaluation of Safety and Efficacy of Keratin Hair Therapy

Not Applicable
Conditions
Hair Damage
Interventions
Procedure: Keratin hair treatment (Keratin Cure ®) versus (QOD Max ®)
Registration Number
NCT04489576
Lead Sponsor
Sohag University
Brief Summary

Hair appearance is an important issue for females. Treatment of hair with keratin has been popular among females nowadays. Although chemical hair straightening application has a beneficial effect on hair shafts with the repair of the broken cuticle, some side effects may occur. Therefore, this study aims to study the efficacy and safety of such new non-formaldehyde widely used keratin treatments on hair by assessment of changes of the scalp, hair density, and the morphology, color, and ultrastructure of hair shaft after application.

Detailed Description

Hair is an important feature for most women that contribute to one's individual identity. The appearance and morphology of the hair is one of the divergent traits in humans. Keratin in hair care products has two effects; it can penetrate the cortex of the hair fiber improving the mechanical properties of damaged fibers and promotes a surface coating that prevents or decreases water diffusion through the hair fibers.These properties have beneficial effects on the hair structure replacing lost keratin.However, the side effects and safety of this treatment have not yet been completely evaluated.There are many different brands of the keratin hair treatment, all with nearly the same basic chemical composition. Non-formaldehyde containing keratin straightening products, also known as safe keratin treatments (SKT) have recently been introduced to the market.Therefore, this study aims to study the efficacy and safety of such new non formaldehyde widely used keratin treatments on hair.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
30
Inclusion Criteria
  • The study will include female patients aged between 18 and 55 years, with hair curl types from III to V according to L'Oréal Curl Classification. The Patients will be randomized by simple randomization into 3 groups, 10 patients for each.
Exclusion Criteria
  • Pregnant and lactating women.
  • Patients having hair loss or under treatment of hair loss in last 3 months.
  • Patients with previous history of keratin treatment.
  • Patients with scalp affection including infection, injury or surgery
  • Patients with chronic medical diseases.
  • Patients with anemia (hemoglobin level <10mg/dl) or under its treatment.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group (3): Treatment without keratin hair treatmentKeratin hair treatment (Keratin Cure ®) versus (QOD Max ®)Group (3): Patients will be treated without keratin hair treatment, but the same steps of keratin application will be followed.
Group (1): Treatment with keratin cure hairKeratin hair treatment (Keratin Cure ®) versus (QOD Max ®)Group (1): Patients will be treated with Keratin cure ® hair treatment. It will be applied once with use of a flat iron.
Group (2): Treatment with Qod max keratin hairKeratin hair treatment (Keratin Cure ®) versus (QOD Max ®)Group (2): Patients will be treated with QOD Max ® keratin hair treatment. It will be applied once with use of a flat iron.
Primary Outcome Measures
NameTimeMethod
Change of hair shedding using the Visual analogue scale (VAS)Baseline, 2 months, 4 months, 6 months

It will be used to evaluate hair shedding. Hair shedding is scored on a scale of 1-6. Women are asked to look at the scale and point to the photograph that best correlates with the amount of hair shed on an average day. Grades 1-3 are considered normal. Grade 4 is borderline, while Grades 5 and 6 indicate excessive shedding.

Change of hair morphology using trichoscopeBaseline, 2 months, 4 months, 6 months

It will be used to evaluate hair structure and scalp. Hair density/cm 2 and thickness (mm) will be measured in the frontal, temporal and vertex areas in all participants.

Change of hair morphology using Transmission Electron Microscopic examinationBaseline, 2 months, 4 months, 6 months

Randomly selected samples of each group will be fixed in 3% glutaraldehyde for over a period of 4 hours at 4°C and processed to be examined by transmission electron microscope

Safety evaluationat 6 months

to detect any side effects that will be reported either by the patient or by the physician.

Secondary Outcome Measures
NameTimeMethod
Change of patient satisfaction questionnaire about keratin treatmentBaseline, 2 months, 4 months, 6 months

A 5 items Questionnaire will be completed by the patients to evaluate their satisfaction about the treatment. The questionnaire consists of Q1 (1-5), Q2,3 (1-7), Q4 (1-4) and Q5 has 3 sub-items Q5a, Q5b, Q5c (1-5 for each). Total score ranges from 7-38. Higher scores are associated with higher dissatisfaction.

Trial Locations

Locations (1)

Sohag University

🇪🇬

Sohag, Egypt

© Copyright 2025. All Rights Reserved by MedPath